Prostate Cancer - Results from #120

Radionuclide therapy in 2025: nuclear medicine options in the treatment of metastatic castration-resistant prostate cancer. February 25, 2025

Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population. February 25, 2025

A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source software. February 25, 2025

The Landscape of Supportive Care Needs Among Prostate Cancer Patients in New Zealand: A Cross-Ethnic Analysis. February 25, 2025

Impact of positive surgical margin location after radical prostatectomy: a network meta-analysis. February 25, 2025

Incorporating indirect MRI information in a CT-based deep learning model for prostate auto-segmentation. February 25, 2025

Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer. February 24, 2025

Inhibition of PIM kinase in tumor-associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy. February 24, 2025

Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients? February 24, 2025

Validation of a digital pathology-based multimodal artificial intelligence biomarker in a prospective, real-world prostate cancer cohort treated with prostatectomy. February 24, 2025

Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis. February 24, 2025

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. February 24, 2025

MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening. February 21, 2025

Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719). February 21, 2025

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. February 21, 2025

Photodynamic therapy for the precise treatment of localized prostate cancer. February 21, 2025

Specificity of a polygenic score for aggressive prostate cancer. February 21, 2025

Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study. February 20, 2025

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer. February 20, 2025

On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancer. February 20, 2025

Page 7 of 1466